| Drug Name |
Felbamate |
| Drug ID |
BADD_D00871 |
| Description |
Felbamate is an anticonvulsant drug used in the treatment of epilepsy. In particular, in the adult patient population, it can be employed to treat partial seizures (with and without generalization). Alternatively, it is used to treat partial and generalized seizures associated with Lennox-Gastaut syndrome in children. It has a weak inhibitory effect on GABA receptor binding sites. |
| Indications and Usage |
For use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use. |
| Marketing Status |
approved |
| ATC Code |
N03AX10 |
| DrugBank ID |
DB00949
|
| KEGG ID |
D00536
|
| MeSH ID |
D000078328
|
| PubChem ID |
3331
|
| TTD Drug ID |
D05KON
|
| NDC Product Code |
51672-4186; 0037-0442; 65162-686; 65162-735; 42385-721; 72578-057; 51672-4172; 62559-730; 62559-731; 63629-1937; 63629-1944; 73223-003; 65162-734; 17381-554; 47621-054; 47781-630; 66689-825; 0037-0430; 70771-1077; 47781-627; 70771-1078; 70954-051; 51525-0431; 0037-0431; 72578-056; 46016-2542; 69988-0032; 51525-0442; 51672-4185; 53746-734; 53746-735; 22365-007; 16714-775; 51525-0430 |
| UNII |
X72RBB02N8
|
| Synonyms |
Felbamate | 2-Phenyl-1,3-propanediol dicarbamate | 2 Phenyl 1,3 propanediol dicarbamate | Taloxa | Felbatol | Felbamyl | ADD-03055 | ADD 03055 | ADD03055 | (3-Carbamoyloxy-2-phenyl-propyl) carbamate | W-554 | W 554 | W554 |
